Caitong International Asset Management Co., LTD Biotechnology

Caitong International Asset Management Co., LTD

$140 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ABUS Arbutus Biopharma Corp	$510M	$2.42 Million 0.0% of portfolio	784	Q2 2025 Reduced 4.74%
VRDN Viridian Therapeutics, Inc.\De	$717M	$2.42 Million 0.0% of portfolio	173	Q2 2025 Added 2.37%
PTGX Protagonist Therapeutics, Inc	$2.68B	$2.27 Million 0.0% of portfolio	41	Q2 2025 Reduced 98.53%
ARGX Argenx Se	$35.3B	$2.21 Million 0.0% of portfolio	4	Q2 2025 Reduced 97.2%
AUPH Aurinia Pharmaceuticals Inc.	$1.61B	$2.19 Million 0.0% of portfolio	259	Q2 2025 New
ARCT Arcturus Therapeutics Holdings Inc.	$396M	$2.06 Million 0.0% of portfolio	158	Q2 2025 New
FDMT 4 D Molecular Therapeutics, Inc.	$199M	$2.03 Million 0.0% of portfolio	546	Q2 2025 New
CYTK Cytokinetics Inc	$3.23B	$1.98 Million 0.0% of portfolio	60	Q2 2025 Added 1,400.0%
ALDX Aldeyra Therapeutics, Inc.	$313M	$1.65 Million 0.0% of portfolio	430	Q2 2025 Added 151.46%
CLDX Celldex Therapeutics, Inc.	$1.11B	$1.59 Million 0.0% of portfolio	78	Q2 2025 Added 143.75%
ENTA Enanta Pharmaceuticals Inc	$142M	$1.47 Million 0.0% of portfolio	195	Q2 2025 Reduced 86.46%
CAPR Capricor Therapeutics, Inc.	$196M	$1.37 Million 0.0% of portfolio	138	Q2 2025 Reduced 99.39%
MIRM Mirum Pharmaceuticals, Inc.	$2.38B	$1.17 Million 0.0% of portfolio	23	Q2 2025 Reduced 96.82%
RARE Ultragenyx Pharmaceutical Inc.	$1.97B	$1.16 Million 0.0% of portfolio	32	Q2 2025 Added 700.0%
VRNA Verona Pharma PLC	$6.41B	$1.14 Million 0.0% of portfolio	12	Q2 2025 Reduced 99.29%
AKBA Akebia Therapeutics, Inc.	$610M	$906,000 0.0% of portfolio	249	Q2 2025 New
UTHR United Therapeutics Corp	$13.7B	$862,000 0.0% of portfolio	3	Q2 2025 New
SCPH Sc Pharmaceuticals Inc.	$132M	$842,000 0.0% of portfolio	221	Q2 2025 New
AGIO Agios Pharmaceuticals, Inc.	$1.94B	$698,000 0.0% of portfolio	21	Q2 2025 Reduced 53.33%
ROIV Roivant Sciences Ltd.	$8.15B	$665,000 0.0% of portfolio	59	Q2 2025 Reduced 11.94%
ETNB 89bio, Inc.	$420M	$638,000 0.0% of portfolio	65	Q2 2025 New
ALLO Allogene Therapeutics, Inc.	$148M	$506,000 0.0% of portfolio	448	Q2 2025 Reduced 28.21%
NVAX Novavax Inc	$663M	$391,000 0.0% of portfolio	62	Q2 2025 Reduced 84.46%
MDXG Mimedx Group, Inc.	$821M	$318,000 0.0% of portfolio	52	Q2 2025 Reduced 54.39%
OMER Omeros Corp	$262M	$312,000 0.0% of portfolio	104	Q2 2025 Reduced 81.85%
CGEN Compugen LTD	$127M	$162,000 0.0% of portfolio	91	Q2 2025 New
ATXS Astria Therapeutics, Inc.	$101M	$123,000 0.0% of portfolio	23	Q2 2025 Reduced 97.49%
LGND Ligand Pharmaceuticals Inc	$2.58B	$114,000 0.0% of portfolio	1	Q2 2025 Reduced 66.67%
IMVT Immunovant, Inc.	$3.55B	$80,000 0.0% of portfolio	5	Q2 2025 Reduced 99.87%
HRMY Harmony Biosciences Holdings, Inc.	$2.1B	$32,000 0.0% of portfolio	1	Q2 2025 Reduced 99.94%
CRNX Crinetics Pharmaceuticals, Inc.	$1.53B	$29,000 0.0% of portfolio	1	Q2 2025 New
ANVS Annovis Bio, Inc.	$22.6M	$2,000 0.0% of portfolio	1	Q2 2025 New
PDSB Pds Biotechnology Corp	$35M	$1,000 0.0% of portfolio	1	Q1 2025 Reduced 99.6%
PYXS Pyxis Oncology, Inc.	$36.5M	$1,000 0.0% of portfolio	1	Q2 2025 Reduced 66.67%
SGMO Sangamo Therapeutics, Inc	$81.4M	$1,000 0.0% of portfolio	1	Q1 2025 Reduced 99.98%
STRO Sutro Biopharma, Inc.	$40.7M	$1,000 0.0% of portfolio	1	Q2 2025 New
TNYA Tenaya Therapeutics, Inc.	$31.4M	$1,000 0.0% of portfolio	1	Q1 2025 New
MRSN Mersana Therapeutics, Inc.	$590M	$0 0.0% of portfolio	1	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.